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Abstract
Background: Long operating time and high blood loss contribute to post-surgical morbidity. Therefore, strategies
to reduce these factors should to be tested using robust methods.
The purpose of this study was to evaluate the impact of using the harmonic scalpel on operating time and blood
loss in patients undergoing resection for advanced oral cancer (OSCC).
Methods: Thirty-six adult head and neck cancer patients with advanced OSCC requiring primary tumor resection
with uni- or bi- lateral selective neck dissection from July 2012 to September 2014 were randomized to either the
control group (traditional surgery) or the experimental group (harmonic surgery). Patients older than 18 years who
were able to provide informed consent were eligible. Primary outcomes of interest were: intraoperative blood loss
(mL) and operative time (minutes) for the ablative part of the surgery.
Results: Mean blood loss in the experimental group was 260 mL versus 403 mL in the control group (p = 0.08).
Mean operative time was 140 min in the experimental group and 159 min in the control group (p = 0.2).
Conclusions: In this randomized controlled trial, use of the harmonic scalpel did not effect intraoperative blood
loss or OR time in patients undergoing surgery for advanced OSCC.
Trial registration: ClinicalTrials.gov, NCT02017834.
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Background
Oral squamous cell cancer (OSCC) is among the top ten
most prevalent malignancies affecting patients world-
wide [1]. When advanced, treatment consists of a multi-
disciplinary approach involving the head and neck
surgeon, radiation oncologist and medical oncologist.
Surgical resection is the primary treatment of OSCC and
can involve both complex resection and reconstruction.
Surgical blood loss and prolonged operating time
adversely impact treatment outcomes in a variety of
surgical procedures including major head and neck
surgery [2–5]. Neck dissection, either uni or bilateral is
usually part of the treatment of advanced OSCC. Major
head and neck resections are commonly performed
using a variety of instruments including sharp dissection
and electrocautery as well as suture ligatures and
surgical clips for additional hemostasis. These common
approaches have stood the test of time but have a
number of potential disadvantages. These disadvantages
include lost time due to frequent instrument passing for
tissue cutting and hemostasis, increased local thermal
tissue damage with electrocautery, supplementary clip-
ping/suture ligatures for hemostasis of larger vessels and
overall decreased operative efficiency and potential for
increased blood loss.
The harmonic scalpel (HS)(Ethicon Endo-Surgery,
Cincinnati, OH) was initially designed and utilized for
laparoscopic surgery nearly two decades ago. Since that
time, the HS has been adapted for use in a broad range
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of head and neck surgical procedures including tonsillec-
tomy, thyroidectomy, glossectomy and submandibular
gland excision [6–14]. The HS reduces intraoperative
blood loss in thyroidectomy and reduced blood loss and
operative time in parotidectomy [6, 9–13, 15]. As a result,
many surgeons preferentially use the HS in order to im-
prove surgical efficiency and reduce surgical bleeding.
Previous studies comparing the HS to standard tech-
niques in selective neck dissection (SND) alone revealed
a significant decrease in operative time, blood loss or
both [16–20]. A recent randomized clinical trial from
our group concluded that the HS is an effective tool for
reducing blood loss in patients undergoing level I-IV
neck dissection [16]. There are no randomized studies
that measure the utility of the HS for oral resection
combined with neck dissection. The addition of an oral
resection with neck dissection has greater associated
blood loss; therefore the HS may prove to be of particu-
lar benefit for these extended procedures.
The purpose of this study was to evaluate, using a pro-
spective randomized design, the impact of the HS on
blood loss and operating time for the surgical treatment
of advanced OSCC. Our hypothesis was that the use of
the HS will reduce both operative blood loss and time.
Methods
This study was a prospective randomized clinical trial
(www.clinicaltrials.gov registration #NCT02017834) under-
taken in a consecutive cohort of patients presenting to the
senior surgeons (T.W.M., S.P.C., J.C.D.). To be eligible, pa-
tients had to be 18 years old and have advanced oral cavity
squamous cell carcinoma (clinical stage T2 or greater)
requiring resection with unilateral or bilateral SND (I-IV).
Patients were excluded if they received previous treatment
for head and neck cancer, were unwilling or unable to
consent to surgery or had a history of a bleeding disorder.
Between July 2012 and September 2014, 36 consecutive
patients presenting with a diagnosis of OSCC were eligible
for this study. All patients provided informed consent to
participate in this trial prior to their enrolment and alloca-
tion. This study was reviewed and approved by the Conjoint
Health Research Ethics Board at the University of Calgary.
Subjects were assigned to either the control or experimen-
tal groups via a predetermined 6 × 6 block randomization.
The random allocation sequence was generated by two
authors (J.C.D, S.C.N.) using randomization.com. Subjects
were enrolled at the pre-operative consultation by one of
the senior surgeons (T.W.M, S.P.C., J.C.D.). Patients were
assigned sequentially to either arm of the study in accord-
ance with the block randomization by the research coordin-
ator (S.C.N), who informed the resecting surgeon one day
prior to the OR. The control group (traditional surgery)
comprised 18 combined oral resections and neck dissections
in which our standard dissection technique (sharp dissection
using scalpel or cutting cautery, surgical ties and/or
clips for hemostasis augmented with bipolar and/or
monopolar cautery) was used. The experimental
group (harmonic surgery) consisted of 18 combined
oral resections and neck dissections performed using
the HS as an adjunct to our standard dissection
technique. Of the 36 patients, the intraoperative out-
comes were improperly measured for 1 patient in
each of the experimental and control groups and they
were therefore excluded from analysis as protocol vio-
lations. The remaining 34 combined procedures
followed the full study protocol with no further exclu-
sions, dropouts or protocol violations. The study flow
diagram can be seen in Fig. 1.
Study protocol
The following protocol was adapted from our previ-
ous work with the HS in neck dissection [16]. All
patients were operated on by 1 of 3 experienced head
and neck oncologic surgeons (T.W.M., S.P.C., J.C.D.)
at the Foothills Medical Centre in Calgary, Alberta,
Canada. Before being permitted to enroll patients to
the study protocol, surgeons were required to indi-
vidually perform 10 combined cases using the HS in
order to become sufficiently proficient in the use of
the device. Preoperative characteristics for all enrolled
subjects including age, sex, body mass index (BMI),
location of primary, cancer staging (TNM) and their
Charlson Comorbidity Index score were collected at
the time of enrollment.
At the time of surgery, the patient was positioned,
prepped and draped using standard protocol. Once the
tracheostomy was performed, the primary lesion and
SND incisions were marked and then injected with
0.25 % Marcaine and 1:100,000 epinephrine. Subplatys-
mal skin flaps were raised prior to recording operative
time and blood loss. Standard bipolar and monopolar
cautery (Valleylab, Inc, Boulder, Colorado) were used in
the traditional surgery patients. In the harmonic surgery
patients, the Harmonic Focus hand piece (Ethicon
Endo-Surgery, Cincinnati, Ohio) was used to perform
the surgical resection. The operating surgeon also select-
ively used surgical clips, bipolar and monopolar cautery
when the neurovascular anatomy precluded the use of
the harmonic scalpel. All other surgical instruments
were identical between the 2 groups. Blood loss was
measured as the combined total of the volume of drain-
age in the suction canister and the weight of the sponges
used (minus the dry weight of the sponges and any irri-
gation used). Operative times were recorded independ-
ently for each SND performed and primary tumor
resection and then totaled. Resident operating time and
experience as potential confounders were mitigated
through the recording the percentage of the total time
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that the resident was operating in addition to the
resident’s post-graduate training year.
In the post-operative period, the secondary out-
come variables were collected at 48 h and at 1 week.
These variables included: post-operative complica-
tions (Clavien complication scale), cumulative drain
outputs (in milliliters), the presence/absence of
abnormalities around the incision site (infection,
hematoma, seroma) and hospital stay (in days). Neck
drains were removed when the 24-h drainage was
less than 25 mL – all drains were left for a mini-
mum of 72 h. Completion of the protocol occurred
at the 1-month period when the presence or absence
of complications as well as the state of the incision
site were recorded at a scheduled follow-up visit.
The trial was concluded when the enrolment object-
ive was acheived.
Statistical analysis
Power and sample size were calculated based on the
two primary outcomes of interest (blood loss, operat-
ing time) using a comparison of means of two inde-
pendent samples (Stata, version 14. Stata Corp.
College Station, Tx, USA). A sensitivity analysis using
our own estimates of OR time and blood loss (based
on clinical experience and review of the literature)
was performed [12]. The sensitivity analysis and
power calculation revealed that a sample size of 13
subjects per arm would allow us to detect a differ-
ence in operative time greater than 20 min and a
difference in blood loss of greater than 200 ml (power
0.9, alpha 0.05). These differences were judged to be
clinically meaningful. In order to allow for potential
study dropouts and protocol violations we elected to
recruit a total of 36 subjects (18 subjects per arm).
Fig. 1 Study flow diagram. HN, head and neck; OR, operating room
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Intergroup differences for the primary outcomes of
interest were compared using a nonparametric test for
independent continuous outcomes (Wilcoxon Rank-sum
test). Categorical variables were compared using a chi-
squared test. A p-value < 0.05 was considered statistically
significant.
Results
All patients enrolled in the study underwent resection
of an advanced OSCC (clinical T2 or greater) in
addition to a unilateral or bilateral SND. Clinicopath-
ologic characteristics of the cohort can be seen in
Table 1. The groups were homogeneous for age, sex,
BMI, TNM staging and comorbidity. Pathologic T and
N stages are reported in Table 1.
Primary outcomes
A comparison of the primary outcomes can be seen in
Table 2 and Fig. 2. Intraoperative blood loss was not sig-
nificantly lower in the experimental group compared to
the control group (260 mL vs. 403 mL, p = 0.08). Two
patients in the experimental group were extreme outliers
in terms of blood loss. The mean total operative time
was 140 min in the experimental group and 159 min in
the control group (p = 0.21). Two subjects were also out-
liers with respect to OR time.
Secondary outcomes
There were 2 vascular injuries (internal jugular vein), 1
in each group. One patient in the harmonic group had a
tumor that required resection of the hypoglossal nerve
and this was recorded as a neurologic complication.
There were no intraoperative adverse events. In the
post-operative period, there were no surgical site com-
plications (seroma, hematoma, wound infection). Other
secondary outcomes are reported in Table 3. There were
no differences between the control and experimental
groups.
Discussion
In this randomized controlled trial we conclude that the
harmonic scalpel had no significant impact on blood loss
or operating time in patients undergoing oral cancer re-
section combined with neck dissection. Two patients in
the harmonic scalpel group had extreme blood loss that
was not explained by any evident surgeon, tumor or
patient factors.
Tirelli et al. [21] performed a non-randomized trial
evaluating the benefits and disadvantages of the HS in
the treatment of 36 patients with oral and oropharyngeal
carcinomas. These authors found a highly significant de-
crease in blood loss in the HS group, but did not differ-
entiate between the oral and oropharyngeal sub-groups.
There was also a significant reduction in OR time in the
harmonic scalpel group. Oral and oropharyngeal cancer
surgery are two distinct entities that can require a num-
ber of different surgical approaches and subsequently
different amounts of surgical time and operative blood
loss. The only disadvantage found by Tirelli et al was a
higher incidence of lymphoedema in the HS group
attributed to complete lymphatic interruption upstream
to dissection. No other difference in complications was






Age at surgery ns
yrs (mean, SD) 61 (9.2) 62 (12.9)
Sex (n, %) ns
Male 11 (65 %) 9 (53 %)
Female 6 (35 %) 8 (47 %)
BMI ns
(mean, SD) 25.7 (0.8) 25.2 (1.4)
pT stage (n, %) ns
T1 2 (12 %) 1 (6 %)
T2 7 (41 %) 4 (24 %)
T3 3 (18 %) 1 (6 %)
T4a 5 (29 %) 11 (65 %)
pN stage (n, %) ns
N0 7 (41 %) 8 (47 %)
N1 6 (35 %) 4 (24 %)
N2b 4 (24 %) 3 (18 %)
N2c 0 2 (12 %)
Overall stage (n, %) ns
I 2 (12 %) 1 (6 %)
II 2 (12 %) 1 (6 %)
III 6 (35 %) 1 (6 %)
IV 7 (41 %) 14 (82 %)
Table 2 Primary outcomes










Operative time, min (mean, 95 % CI) 140 [120–161] 159 [134–184] ns 140 [119–161] 147 [127–166] ns
Intraoperative blood loss, mL (mean, 95 % CI) 260 [171–349] 403 [261–545] ns 207 [158–257] 403 [261–545] 0.01
Wilcoxon Rank-sum Test
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found between the two groups. The Tirelli study and
ours are not directly comparable due to the differences
in tumour sites and study design.
Our group [16], and others, have demonstrated the
HS to be an effective tool in reducing operative blood
loss in neck dissection. In this study the addition of
the oral cavity resection seems to minimize the im-
pact of the HS. Examination of the raw data revealed
that the 2 outliers in the HS group strongly influ-
enced the results and perhaps a larger study might
show a beneficial effect of the HS on blood loss.
However, our study was adequately powered to detect
the magnitude of difference it set out to and the
results are therefore valid. Similar to our previous
study, we did not find a significant reduction in
operative time when using the HS. This finding is in
contrast to other studies that suggest that the HS is
effective in reducing OR time. We cannot explain the
discrepancy between our findings and others but we
are confident that our prospective randomized study
design is robust.
Despite the randomized study design we believe there
are some limitations to this research. This was a single
institutional study with 3 experienced head and neck
surgeons performing advanced oral cancer resections
and neck dissections. This potentially limits the
generalizability of the findings. A multicenter study
could reduce any surgical technique bias produced by
evaluating surgeons from a single center. Our experience
using the HS in oral resection suggests that it might be a
useful tool in reducing blood loss in some patients but it
is by no means a panacea that should be universally
applied.
Conclusions
In conclusion, our study is the first randomized trial
to evaluate the harmonic scalpel in the treatment of
advanced OSCC. Despite our clinical impression, we
did not find significant differences in OR time or
blood loss between the 2 treatment groups. A multi-
centre clinical trial would be a useful next step in
determining the true value of the harmonic scalpel in
major head and neck resection.
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Fig. 2 Primary outcomes







Vascular complications 1 1 ns
Neurologic complications 1 0 ns
Surgical drain output
48-h, mL (mean, 95 % CI) 160 [107–213] 119 [84–154] ns
1-week, mL (mean, 95 % CI) 214 [142–285] 185 [102–268] ns
Hospital stay, days
(mean, 95 % CI)
14 [11–18] 15 [12–18] ns
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